Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38023
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVRANCKX, Pascal-
dc.contributor.authorValgimigli, Marco-
dc.date.accessioned2022-09-08T12:40:45Z-
dc.date.available2022-09-08T12:40:45Z-
dc.date.issued2022-
dc.date.submitted2022-09-07T14:13:43Z-
dc.identifier.citationEuroIntervention, 18 (4) , p. E267 -E268-
dc.identifier.urihttp://hdl.handle.net/1942/38023-
dc.language.isoen-
dc.publisherEUROPA EDITION-
dc.subject.otherAnticoagulants-
dc.subject.otherDrug Therapy, Combination-
dc.subject.otherFibrinolytic Agents-
dc.subject.otherHumans-
dc.subject.otherPlatelet Aggregation Inhibitors-
dc.subject.otherAtrial Fibrillation-
dc.subject.otherPercutaneous Coronary Intervention-
dc.titleAntithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!-
dc.typeJournal Contribution-
dc.identifier.epageE268-
dc.identifier.issue4-
dc.identifier.spageE267-
dc.identifier.volume18-
local.format.pages2-
local.bibliographicCitation.jcatA2-
dc.description.notesVranckx, P (corresponding author), Jessa Ziekenhuis, Hartctr Hasselt, Stadsomvaart 11, B-3500 Hasselt, Belgium.-
dc.description.notesPascal.Vranckx@jessazh.be-
local.publisher.place19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6, 31015, FRANCE-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.doi10.4244/EIJ-E-22-00004-
dc.identifier.pmid35866255-
dc.identifier.isi000840791900001-
local.provider.typewosris-
local.description.affiliation[Vranckx, Pascal] Jessa Ziekenhuis, Hartctr Hasselt, Dept Cardiol & Crit Care Med, Hasselt, Belgium.-
local.description.affiliation[Vranckx, Pascal] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.-
local.description.affiliation[Valgimigli, Marco] Univ Svizzera Italiana USI, Ente Osped Cantonale, Ist Cardioctr Ticino, Lugano, Switzerland.-
local.uhasselt.internationalyes-
item.fullcitationVRANCKX, Pascal & Valgimigli, Marco (2022) Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!. In: EuroIntervention, 18 (4) , p. E267 -E268.-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
item.contributorVRANCKX, Pascal-
item.contributorValgimigli, Marco-
crisitem.journal.issn1774-024X-
crisitem.journal.eissn1969-6213-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
The antithrombotic therapy.pdf
  Restricted Access		Peer-reviewed author version548.91 kBAdobe PDFView/Open    Request a copy
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction! - EuroIntervention.pdf
  Restricted Access		Published version244.61 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.